CTS Corporation Lifts FY 2026 Outlook, Showcases Record Margins in Investor Presentation
CTS sits 68% above its 52-week low of $36.025.
Summary
In a July 2026 investor presentation, CTS Corporation raised its FY 2026 guidance to revenue of $565–$585 million and adjusted diluted EPS of $2.55–$2.70, driven by strong diversified market growth and record margins.
Key Events · Earnings and Guidance · CTS
-
FY 2026 Guidance Raised
Revenue guidance was lifted to $565–$585 million, and adjusted diluted EPS to $2.55–$2.70, up from prior implied ranges, reflecting strong Q2 performance and continued momentum in diversified end markets.
-
Record Margins Achieved
LTM adjusted EBITDA margin reached 24%, with adjusted gross margin of 39.8% and adjusted operating margin of 17.5%, demonstrating operational leverage and successful diversification away from transportation.
-
Diversified Markets Driving Growth
Diversified end markets—industrial, medical, aerospace & defense—now represent 58% of LTM revenue, with industrial up 17% YoY and medical up 34% YoY, offsetting a 2% decline in transportation.
-
Capital Allocation Framework Reiterated
CTS plans to allocate 60–80% of free cash flow to acquisitions, 20–40% to dividends and buybacks, and maintain leverage of 1.0–2.5x, with $314 million returned to shareholders since 2013.
Analysis · CTS · Manufacturing
An investor presentation furnished by CTS Corporation raises full-year 2026 guidance for both revenue and adjusted diluted EPS, underscoring robust execution and expansion across diversified end markets. The revised outlook—revenue of $565–$585 million and adjusted EPS of $2.55–$2.70—reflects management's confidence in sustaining momentum even amid macro uncertainty. The presentation also highlights a record LTM adjusted EBITDA margin of 24% and a clear capital allocation framework, reinforcing the investment case for a mid-cap manufacturer executing a diversification strategy.
At the time of this filing, CTS was trading at $60.41 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $36.03 to $69.55. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.